HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Eduard Montanya Selected Research
Eduard Montanya Research Topics
Disease
14
Type 2 Diabetes Mellitus (MODY)
01/2022 - 07/2009
5
Hypoglycemia (Reactive Hypoglycemia)
05/2018 - 06/2010
4
Body Weight (Weight, Body)
01/2022 - 06/2010
4
Hyperglycemia
01/2020 - 01/2007
4
Weight Loss (Weight Reduction)
12/2019 - 07/2009
4
Necrosis
03/2018 - 01/2002
4
Nausea
06/2010 - 07/2009
3
Insulin Resistance
01/2022 - 08/2010
3
Periodontitis
06/2020 - 01/2018
3
Diabetes Mellitus
02/2019 - 01/2016
2
Inflammation (Inflammations)
01/2007 - 01/2007
1
Hypertension (High Blood Pressure)
10/2021
1
Tooth Loss
06/2020
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2019
1
Pancreatitis
12/2016
1
Brain Death (Brain Dead)
12/2016
1
Hyperplasia
01/2016
1
Glucose Intolerance
06/2014
1
Weight Gain
01/2013
1
Hypoxia (Hypoxemia)
08/2011
1
Type 1 Diabetes Mellitus (Autoimmune Diabetes)
10/2009
1
Adenoma (Adenomas)
03/2007
1
Pituitary ACTH Hypersecretion
03/2007
1
Diabetic Nephropathies (Diabetic Nephropathy)
10/2005
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
08/2002
1
Combined Pituitary Hormone Deficiency
08/2002
Drug/Important Bio-Agent (IBA)
8
Glucose (Dextrose)
FDA Link
Generic
02/2019 - 07/2009
7
Metformin (Glucophage)
FDA Link
Generic
12/2019 - 07/2009
7
Liraglutide
FDA Link
01/2013 - 07/2009
6
Glucagon-Like Peptide 1 (GLP 1)
IBA
12/2019 - 07/2009
5
Insulin (Novolin)
FDA Link
01/2022 - 08/2011
3
Exenatide (Byetta)
FDA Link
01/2013 - 07/2009
3
Sitagliptin Phosphate (Januvia)
FDA Link
01/2013 - 04/2010
2
semaglutide
IBA
01/2022 - 12/2019
2
Everolimus
FDA Link
11/2018 - 01/2016
2
Ligands
IBA
03/2018 - 01/2018
2
Toll-Like Receptors (Toll-Like Receptor)
IBA
03/2018 - 01/2018
2
NF-kappa B (NF-kB)
IBA
03/2018 - 01/2018
2
Interleukin-6 Receptors (Interleukin 6 Receptor)
IBA
03/2018 - 01/2018
2
Osteoprotegerin
IBA
03/2018 - 01/2018
2
Interleukins
IBA
03/2018 - 01/2018
2
Dipeptidyl-Peptidase IV Inhibitors
IBA
10/2012 - 04/2010
2
Hypoglycemic Agents (Hypoglycemics)
IBA
11/2009 - 07/2009
2
Interleukin-1beta (Interleukin 1 beta)
IBA
10/2009 - 01/2007
2
Cytokines
IBA
01/2007 - 01/2007
1
ORALIT (ORS)
IBA
10/2021
1
Particulate Matter
IBA
10/2021
1
Tuberculin (PPD)
IBA
06/2020
1
Sodium-Glucose Transport Proteins
IBA
12/2019
1
empagliflozin
IBA
12/2019
1
Incretins
IBA
12/2016
1
Polymers
IBA
01/2016
1
Glycated Hemoglobin (Glycosylated Hemoglobin)
IBA
01/2013
1
Glucagon-Like Peptide-1 Receptor Agonists
IBA
07/2012
1
Glucagon (Glukagon)
FDA Link
07/2012
1
Glucagon-Like Peptide-1 Receptor
IBA
07/2012
1
Proinsulin
IBA
08/2011
1
Blood Glucose (Blood Sugar)
IBA
08/2011
1
Gastrins
IBA
07/2011
1
clofibride
IBA
04/2010
1
Chromatin
IBA
03/2010
1
Hydrocortisone (Cortisol)
FDA Link
Generic
03/2007
1
Nitric Oxide Synthase (NO Synthase)
IBA
01/2007
1
Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
IBA
10/2005
1
Diltiazem (Cardizem)
FDA Link
Generic
10/2005
Therapy/Procedure
5
Islets of Langerhans Transplantation
01/2020 - 01/2007
3
Transplantation
01/2008 - 01/2005
2
Stents
11/2018 - 01/2016
2
Drug Therapy (Chemotherapy)
01/2018 - 08/2002
2
Therapeutics
12/2016 - 07/2009
2
Glycemic Control
01/2016 - 06/2010
1
Home Care Dental Devices (Dental Floss)
06/2020
1
Chemoradiotherapy
02/2019
1
Subcutaneous Injections
11/2009
1
Isogeneic Transplantation
01/2002